ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
3 announcements with these filters
Sun Pharma has been assigned international issuer credit ratings of Baa1 by Moody’s and BBB+ by S&P. These investment-grade ratings reflect the company's strong financial profile.
CRISIL reaffirmed Sun Pharmaceutical Industries' long-term bank facilities rating at 'CRISIL AAA/Stable'. The 'Rating Watch with Developing Implications' status has been officially removed.
Sun Pharmaceutical Industries Limited announced that CRISIL and ICRA reaffirmed its 'AAA' and 'A1+' ratings. CRISIL placed the long-term rating on 'Watch with Developing Implications' following Sun Pharma's agreement to acquire Organon & Co.